Lauren G Gilstrap

Suggest Changes
Learn More
BACKGROUND Guidelines recommend continuation or initiation of guideline-directed medical therapy, including angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEi/ARB), in(More)